Identifying women with increased risk of breast cancer and implementing risk-reducing strategies and supplemental imaging

被引:0
|
作者
Suneela Vegunta
Asha A. Bhatt
Sadia A. Choudhery
Sandhya Pruthi
Aparna S. Kaur
机构
[1] Mayo Clinic,Division of Women’s Health Internal Medicine
[2] Mayo Clinic,Department of Radiology
[3] Mayo Clinic,Division of General Internal Medicine, Breast Cancer Clinic
来源
Breast Cancer | 2022年 / 29卷
关键词
BRCA; Breast MRI; Dense breast tissue; Risk-assessment models; Risk factors for breast cancer;
D O I
暂无
中图分类号
学科分类号
摘要
Breast cancer (BC) is the second most common cancer in women, affecting 1 in 8 women in the United States (12.5%) in their lifetime. However, some women have a higher lifetime risk of BC because of genetic and lifestyle factors, mammographic breast density, and reproductive and hormonal factors. Because BC risk is variable, screening and prevention strategies should be individualized after considering patient-specific risk factors. Thus, health care professionals need to be able to assess risk profiles, identify high-risk women, and individualize screening and prevention strategies through a shared decision-making process. In this article, we review the risk factors for BC, risk-assessment models that identify high-risk patients, and preventive medications and lifestyle modifications that may decrease risk. We also discuss the benefits and limitations of various supplemental screening methods.
引用
收藏
页码:19 / 29
页数:10
相关论文
共 50 条
  • [21] The effect of hormone therapy on breast density following risk-reducing salpingo-oophorectomy in women with an increased risk for breast and ovarian cancer
    van Barele, Mark
    Buis, Chistien C. M.
    Brood-van Zanten, Monique M. A.
    van Doorn, H. Lena C.
    Gaarenstroom, Katja N.
    Heemskerk-Gerritsen, Bernadette A. M.
    Hooning, Maartje J.
    de Hullu, Joanne
    Mourits, Marian J.
    Burger, Curt W.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2021, 28 (11): : 1307 - 1312
  • [22] Risk-reducing surgery in women with familial susceptibility for breast and/or ovarian cancer
    Antill, Y
    Reynolds, J
    Young, MA
    Kirk, J
    Tucker, K
    Bogtstra, T
    Wong, S
    Dudding, T
    Di Iulio, J
    Phillips, KA
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (05) : 621 - 628
  • [23] Identifying and counseling women at increased risk for breast cancer
    Rhodes, DJ
    MAYO CLINIC PROCEEDINGS, 2002, 77 (04) : 355 - 361
  • [24] Breast cancer risk-reducing surgery in Helsinki
    Puustinen, L.
    Svarvar, C.
    Aittomaki, K.
    Suominen, S.
    Jahkola, T.
    EJC SUPPLEMENTS, 2010, 8 (03): : 136 - 137
  • [25] Bone mineral density and fractures after risk-reducing salpingo-oophorectomy in women at increased risk for breast and ovarian cancer
    Fakkert, Ingrid E.
    Abma, Elske Marije
    Westrik, Iris G.
    Lefrandt, Joop D.
    Wolffenbuttel, Bruce H. R.
    Oosterwijk, Jan C.
    Slart, Riemer H. J. A.
    van der Veer, Eveline
    de Bock, Geertruida H.
    Mourits, Marian J. E.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (03) : 400 - 408
  • [26] Elevated Bone Turnover Markers after Risk-Reducing Salpingo-Oophorectomy in Women at Increased Risk for Breast and Ovarian Cancer
    Fakkert, Ingrid E.
    van der Veer, Eveline
    Abma, Elske Marije
    Lefrandt, Joop D.
    Wolffenbuttel, Bruce H. R.
    Oosterwijk, Jan C.
    Slart, Riemer H. J. A.
    Westrik, Iris G.
    de Bock, Geertruida H.
    Mourits, Marian J. E.
    PLOS ONE, 2017, 12 (01):
  • [27] Motivators and barriers of tamoxifen use as risk-reducing medication amongst women at increased breast cancer risk: a systematic literature review
    Meiser, B.
    Wong, W. K. T.
    Peate, M.
    Julian-Reynier, C.
    Kirk, J.
    Mitchell, G.
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2017, 15
  • [28] Motivators and barriers of tamoxifen use as risk-reducing medication amongst women at increased breast cancer risk: a systematic literature review
    B. Meiser
    W. K. T. Wong
    M. Peate
    C. Julian-Reynier
    J. Kirk
    G. Mitchell
    Hereditary Cancer in Clinical Practice, 15
  • [29] Risk-Reducing Oophorectomy and Breast Cancer Risk Across the Spectrum of Familial Risk
    Terry, Mary Beth
    Daly, Mary B.
    Phillips, Kelly Anne
    Ma, Xinran
    Zeinomar, Nur
    Leoce, Nicole
    Dite, Gillian S.
    MacInnis, Robert J.
    Chung, Wendy K.
    Knight, Julia A.
    Southey, Melissa C.
    Milne, Roger L.
    Goldgar, David
    Giles, Graham G.
    Weideman, Prue C.
    Glendon, Gord
    Buchsbaum, Richard
    Andrulis, Irene L.
    John, Esther M.
    Buys, Saundra S.
    Hopper, John L.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2019, 111 (03): : 331 - 334
  • [30] An integrated model of risk and risk-reducing strategies
    Cho, J
    Lee, J
    JOURNAL OF BUSINESS RESEARCH, 2006, 59 (01) : 112 - 120